FAST TRACK GROUP Announces Closing of $15 Million Initial Public Offering
SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) -- FAST TRACK GROUP (NASDAQ: FTRK) ('Fast Track' or the 'Company'), a leading entertainment-focused event management and celebrity agency company, today announced the closing of its initial public offering of 3,750,000 ordinary shares (the 'Ordinary Shares') at a public offering price of $4.00 per share, for aggregate gross proceeds of approximately $15 million, prior to deducting underwriting discounts and other offering expenses. The Company's Ordinary Shares began trading on the Nasdaq Capital Market on May 23, 2025, under the symbol 'FTRK'.
In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 562,500 Ordinary Shares at the public offering price per share, less the underwriting discount, to cover over-allotments, if any.
Alexander Capital, L.P. ('Alexander Capital'), a full-service broker/dealer, acted as the lead book-running manager with Network 1 Financial Securities, Inc. acting as a co-underwriter for the offering. Loeb & Loeb LLP, Harney Westwood & Riegels Singapore LLP, and Rajah & Tann Singapore LLP served as U.S., Cayman Islands, and Singapore legal counsel to the Company, respectively, and Akerman LLP served as U.S. legal counsel to Alexander Capital for the offering.
The offering is being conducted pursuant to the Company's registration statement on Form F-1, as amended (File No. 333-286542), relating to the Ordinary Shares initially filed with the U.S. Securities and Exchange Commission (the 'SEC') on September 6, 2024, and was declared effective on May 22, 2025. The offering was made only by means of a prospectus. A final prospectus relating to the offering has been filed with the SEC on May 23, 2025, and is available on the SEC's website at www.sec.gov. Copies of the final prospectus related to the Offering may be obtained from Alexander Capital, L.P., 10 Drs James Parker Blvd, Suite 202, Red Bank, New Jersey 07701, by telephone at 212-687-5650 or by email at info@alexandercapitallp.com.
Before you invest, you should read the prospectus and other documents the Company has filed or will file with the SEC for more information about the Company and the offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About FAST TRACK GROUPFAST TRACK GROUP is a leading entertainment-focused event management and celebrity agency company. Since inception in Singapore in 2012, the Company has expanded across Asia Pacific, earning a reputation for being the preferred partner for event and endorsement organizers in the region. FAST TRACK GROUP goes beyond traditional event management, offering value-added services such as media planning, PR management, technical production planning, celebrity sourcing, celebrity engagement consultancy and event manpower support, all tailored to the highest standards.
Cautionary Note Regarding Forward-Looking StatementsCertain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations. Investors can find many (but not all) of these statements by the use of words such as 'approximates,' 'believes,' 'hopes,' 'expects,' 'anticipates,' 'estimates,' 'projects,' 'intends,' 'plans,' 'will,' 'would,' 'should,' 'could,' 'may' or other similar expressions. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct. The Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to read the risk factors contained in the Company's final prospectus and other reports it files with the SEC before making any investment decisions regarding the Company's securities. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law.
Investor RelationsJohn Yi and Steven ShinmachiGateway Group, Inc.949-574-3860FTRK@gateway-grp.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
The 3 Best Nasdaq-100 Stocks in 2025: Wall Street Says Buy One and Sell the Others
Palantir, Zscaler, and MercadoLibre are the three best-performing Nasdaq-100 stocks year to date, but most Wall Street analysts see downside in two of the tickers. Palantir is a recognized leader in decision intelligence software, but it's also the most expensive software stock on the market by a wide margin. MercadoLibre has fortified its retail business with add-on merchant services like advertising and logistics, and the stock's current valuation is reasonable. 10 stocks we like better than Palantir Technologies › The Nasdaq-100 measures the performance of 100 large non-financial companies listed on the Nasdaq Stock Exchange. Year to date, the three best-performing stocks in the index are Palantir Technologies (NASDAQ: PLTR), Zscaler (NASDAQ: ZS), and MercadoLibre (NASDAQ: MELI) as of June 8. But forecasts from Wall Street show downside in two of the three tickers, as detailed below: Palantir stock is up 69% year to date. But the median target price of $100 per share implies 21% downside from the current share price of $127. Zscaler stock is up 68% year to date. But the median target price of $300 per share implies 1% downside from the current share price of $303. MercadoLibre stock is up 46% year to date. And the median target price of $2,875 per share implies 15% upside from its current share price of $2,485. The median target prices listed above imply investors should sell Palantir and Zscaler, but buy MercadoLibre. Here are the important details. Palantir develops in analytics software for commercial and government customers. Recently, the International Data Corporation (IDC) recognized the company as the leader in decision intelligence platforms, and Forrester Research ranked it as a technology leader in artificial intelligence and machine learning platforms. Palantir announced encouraging financial results for the first quarter. Revenue increased 39% to $884 million, the seventh consecutive acceleration. And non-GAAP net income increased 62% to $0.13 per diluted share. Management also raised full-year guidance such that revenue is projected to increase 36% in 2025, citing demand for its artificial intelligence platform as a key tailwind. Indeed, IDC estimates AI platform spending will increase at 41% annually through 2028, and Palantir is clearly top of mind for many businesses given the recent recognition from two independent research organizations. The only problem is valuation. Palantir is the most expensive software stock in terms of its forward price-to-sales (PS) ratio by a wide margin. In fact, Palantir would still be the most expensive software stock if its price was cut in half, according to Brent Thill at Jefferies. "Even if you assume they were able to grow at 40% or 50% for the next five years straight, five years from now it would still be the most expensive name in software," he said. To that end, I think investors should avoid Palantir at the present time, and shareholders with large positions should consider trimming. Zscaler operates the largest network security cloud. Its security service edge (SSE) platform modernizes corporate networks by inspecting web traffic and enforcing zero trust policies in the cloud rather than private data centers. That eliminates the need for expensive on-premises security appliances, and lets users quickly and securely access company applications and resources from any device or location. Zscaler reported excellent financial results in the third quarter of fiscal 2025, which ended in April. Revenue increased 23% to $678 million and non-GAAP net income increased 18% to $0.84 per diluted share. Management also raised full-year guidance, such that revenue is forecast to increase 23% in fiscal 2025. Consultancy Gartner recently ranked Zscaler as a leader in SSE platforms for the fourth straight year, and the SSE market will expand at 27% annually through 2030, according to Grand View Research. That gives Zscaler a good shot at annual sales growth exceeding 20% through the end of the decade, especially when the company values its serviceable market at $96 billion. However, Wall Street expects Zscaler's adjusted earnings to grow at 9% annually through fiscal 2026, which ends in July 2026. That makes the current valuation of 93 times earnings look very expensive. Admittedly, the company beat the consensus estimate by an average of 23% in the last six quarters, but the stock would be pricey even if that trend continues. MercadoLibre runs the largest online marketplace in Latin America. It accounted for 28.5% of regional retail e-commerce sales last year, more than its next 15 competitors combined, and eMarketer expects that figure to hit 30% by 2026. One reason the company has been so successful is its ability to support sellers with add-on services like payment processing, credit, advertising, and logistics. MercadoLibre operates the fastest and most expansive delivery network in Latin America. While building that infrastructure is costly, it is also increasing e-commerce penetration across Latin America, while keeping the company ahead of competitors, per eMarketer. MercadoLibre is also the largest retail advertiser in the region, and it has a thriving fintech business. MercadoLibre reported strong financial results in the first quarter. Revenue increased 37% to $5.9 billion on particularly strong sales growth in the fintech segment, which itself was due to strong adoption of credit and asset management products. Meanwhile, GAAP net income increased 44% to $9.74 per diluted share. Wall Street expects MercadoLibre's earnings to increase at 36% annually through 2026. That makes the current valuation of 61 times earnings look reasonable. In my opinion, Wall Street has these three stock pegged correctly: At current prices, MercadoLibre is the most compelling buy, Palantir is the most likely to decline, and Zscaler is somewhere in the middle. Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 173% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Trevor Jennewine has positions in MercadoLibre, Palantir Technologies, and Zscaler. The Motley Fool has positions in and recommends Jefferies Financial Group, MercadoLibre, Palantir Technologies, and Zscaler. The Motley Fool recommends Gartner. The Motley Fool has a disclosure policy. The 3 Best Nasdaq-100 Stocks in 2025: Wall Street Says Buy One and Sell the Others was originally published by The Motley Fool
USA Today
8 minutes ago
- USA Today
US stock futures lower after US, China reach trade deal that awaits presidential sign offs
US stock futures lower after US, China reach trade deal that awaits presidential sign offs Show Caption Hide Caption White House confirms deadline for international trade deals White House Press Secretary Karoline Leavitt confirmed the administration has sent a letter to all of its trading partners ahead of a tariff deadline. U.S. stock futures are lower before May inflation data and details of a U.S.-China trade deal. After two days of talks in London, U.S. and China representatives said they reached a trade agreement and will now seek approval on the framework from the U.S. and Chinese presidents, before implementing it. The deal includes the U.S. rolling back some export restrictions on advanced technology in exchange for China's releasing more rare earths. In other trade news, President Donald Trump's administration is close to a deal with Mexico to lift the 50% tariff on a limited amount of imported steel, according to Bloomberg. Separately, an appeals court also granted the Trump administration's request to keep the president's far-reaching tariffs in effect for now but agreed to fast track the case to hear oral arguments on July 31. Before the opening bell, investors will also see May inflation. May reflects the first full month of price data since Trump announced his aggressive tariff plan on April 2. Economists polled by Dow Jones expect a 0.2% month-over-month increase for a 2.4% annual increase. Treasury Secretary Bessent will testify at 10 a.m. ET to Congress. Futures linked to the blue-chip Dow fell -0.19%, while broad S&P 500 futures dropped -0.20% and tech-heavy Nasdaq futures slipped -0.20%. Corporate news Dave & Buster's reaffirmed its full-year guidance and said data so far in June were encouraging. GitLab topped analyst estimates in the company's first three months of the year but its second-quarter outlook was soft. GameStop's revenues in the first three months of the year missed analysts' expectations. (The story was updated with new information.) Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday.
Associated Press
9 minutes ago
- Associated Press
Investors of Iovance Biotherapeutics, Inc. (IOVA) Have Until July 14, 2025 To Seek a Leadership Role In The Class Action Lawsuit
NEW YORK, NY - June 10, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Iovance Biotherapeutics, Inc. ('Iovance' or the 'Company') (NASDAQ: IOVA) on behalf of investors that purchased or otherwise acquired Iovance securities between May 9, 2024 and May 8, 2025 (the 'Class Period'). CLICK HERE TO JOIN THE CASE If you are an investor in Iovance and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (212) 329-8571. DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than July 14, 2025 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery. On May 8, 2025, after the markets closed, Iovance announced its first quarter 2025 financial results. The Company revealed that total product revenue for the quarter was $49.3 million, a decline from the prior quarter's reported revenue of $73.7 million. The Company also disclosed that full fiscal year 2025 revenue guidance was being revised to $250 million to $300 million from previous guidance of $450 million to $475 million. Iovance stated that it was 'revising full-year 2025 revenue guidance to reflect recent launch dynamics' of the Company's T cell immunotherapy, Amtagvi (lifileucel). Amtagvi was approved by the U.S. Food and Drug Administration in February 2024 and was commercially launched in the first half of 2024. Following this news, the price of Iovance stock fell $1.42 per share, nearly 45%, to close at $1.75 per share on May 9, 2025. The complaint alleges, among other things, that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that Defendants, (i) new Authorized Treatment Centers were experiencing longer timelines to begin treating patients with Amtagvi; (ii) the Company's sales team and new ATCs were ineffective in patient identification and patient selection for Amtagvi, leading to higher patient drop-offs; and (iii) the foregoing dynamics led to higher costs and lower revenue because ATCs could not keep pace with manufactured product. WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this Notice, your rights, or your interests, please contact: CONTACT: Jeffrey P. Campisi KAPLAN FOX & KILSHEIMER LLP 800 Third Avenue, 38th Floor New York, New York 10022 (212) 329-8571 [email protected] Laurence D. King KAPLAN FOX & KILSHEIMER LLP 1999 Harrison Street, Suite 1560 Oakland, California 94612 (415) 772-4704 [email protected] Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client. View the original release on
